2 c. 3 d. 5 Feedback For 2023, Centene will be offering plans to over 51 million Prior period SG&A expenses have been conformed to the current presentation. Financial and other information about Centene is routinely posted and is accessible on Centene's investor relations website, https://investors.centene.com/. Amazon has stopped selling its three Halo products Any reduction in the "Incurred related to: Prior period" amount may be offset as Centene actuarially determines "Incurred related to: Current period." As such, only in the absence of a consistent reserving methodology would favorable development of prior period claims liability estimates reduce medical costs. Adjusted diluted Specifically, the Company believes the presentation of non-GAAP financial information that excludes amortization of acquired intangible assets and acquisition and divestiture related expenses, as well as other items, allows investors to develop a more meaningful understanding of the Company's core performance over time. Ticketmelon was founded in 2015. healthcare services. For the first quarter of 2023, premium and service revenues increased 2% to $35.0 billion from $34.2 billion in the comparable period of 2022. Let's tackle 2023 and then get to 2024. "We look forward to sharing more about Centene's long-term strategy and our plan to deliver profitable growth and increasing value to shareholders into the future during our investor day.". (4)Medicaid and Medicare membership includes 1,291,300, 1,285,600, 1,252,600, 1,231,500, and 1,178,000 dual-eligible beneficiaries for the periods ending December31, 2022, September30, 2022, June 30, 2022, March 31, 2022, and December31, 2021, respectively. The majority of the excess unregulated cash and cash equivalents was utilized in January 2023 to complete planned pass-through payments. for the three months ended December 31, 2022: impairments of assets associated with the divestitures of our Centurion and HealthSmart businesses of $0.52 ($0.37 after-tax); Magellan Rx divestiture gain of $0.47 ($0.17 after-tax); Health Net Federal Services asset impairment of $0.41 ($0.40 after-tax); real estate impairments of $0.11 ($0.09 after-tax); and gain on debt extinguishment related to the repurchases of senior notes of $0.01 ($0.01 after-tax); for the twelve months ended December 31, 2022: real estate impairments of $2.82 ($2.08 after-tax); PANTHERx divestiture gain of $0.84 ($0.65 after-tax); impairments of assets associated with the divestitures of our Spanish and Central European, Centurion, and HealthSmart businesses of $0.78 ($0.60 after-tax); Magellan Rx divestiture gain of $0.46 per share ($0.17 after-tax); Health Net Federal Services asset impairment of $0.40 ($0.39 after-tax); gain on debt extinguishment of $0.04 ($0.03 after-tax); increase to the previously reported gain related to the divestiture of USMM due to the finalization of working capital adjustments of $0.02 ($0.02 after-tax); and costs related to the PBM legal settlement of $0.01 ($0.00 after-tax). Operator. For the second quarter of 2022, total revenues increased 16% to $35.9 billion from $31.0 billion in the The income tax effects of adjustments are based on the effective income tax rates applicable to each adjustment. The 2022 effective tax rate is driven by the tax effects of pending and completed divestitures and impairments associated with our ongoing portfolio review, including the Magellan Rx divestiture gain, the non-deductible impairment of our Health Net Federal Services business, and tax impacts related to the reclassification of the Magellan Specialty Health business to held for sale. Our whole health approach and extensive community Membership includes Aged, Blind, and Disabled (ABD), Intellectual and Developmental Disabilities (IDD), Long-Term Services and Supports (LTSS), and Medicare-Medicaid Plans (MMP) Duals. The Company also contracts with other healthcare and commercial organizations to provide a variety of specialty services focused on treating the whole person. The effective tax rate was 644.4% for the fourth quarter of 2022, compared to 14.6% in the fourth quarter of 2021. WebCentene's 2023 product expansion represents a __% increase from 2022. "We are pleased with the progress we have made on our Value Creation Plan in 2022. Net income of $5.0 billion, an increase of 6.5 percent from first-quarter 2022, and adjusted EBITDA 1 of $11.9 billion, down 1.1 percent year over year. The following table provides a reconciliation of cash, cash equivalents, and restricted cash and cash equivalents reported within the Consolidated Balance Sheets to the totals above: Restricted cash and cash equivalents, included in restricted deposits, Total cash, cash equivalents, and restricted cash and cash equivalents. All forward-looking statements included in this press release are based on information available to us on the date hereof. WebQuestion text Centene's 2023 product expansion represents a __% increase from 2022. a. for the three months ended December 31, 2021: gain related to the divestiture of USMM of $0.25 ($0.23 after-tax) and PBM legal settlement expense of $0.00 ($0.04 after-tax); for the twelve months ended December 31, 2021: PBM legal settlement expense of $2.14 ($1.76 after-tax); gain related to the acquisition of the remaining 60% interest of Circle Health of $0.52 ($0.52 after-tax); impairment of our equity method investment in RxAdvance of $0.39 ($0.32 after-tax); gain related to the divestiture of USMM of $0.25 ($0.23 after-tax); debt extinguishment costs of $0.21 ($0.16 after-tax); reduction to the previously reported gain on divestiture of certain products of our Illinois health plan of $0.10 per share ($0.08 after-tax); and severance costs due to a restructuring of $0.09 ($0.06 after-tax). These statements are not guarantees of future performance and are subject to risks, uncertainties, and assumptions. In total, the Company repurchased 35.7 million shares for $3.0 billion through the stock repurchase program for the full year 2022. The increases were driven by growth in the The Company references adjusted effective tax rate guidance, which excludes acquisition related expenses and amortization of acquired intangible assets, as well as other items. Membership includes Temporary Assistance for Needy Families (TANF), Medicaid Expansion, Children's Health, Membership includes Aged, Blind, or Disabled (ABD), Intellectual and Developmental Disabilities (IDD), Long-Term, Medicaid and Medicare membership includes 1,323,000 and 1,231,500 Dual Eligible Special Needs Plans (D-SNP). During the fourth quarter of 2022, the Company repurchased 17.0 million shares for $1.4 billion. Cash flow provided by operations for the full year 2022 was. and Terms and For the full year of 2022, our effective tax rate on adjusted earnings was 25.8%, compared to 25.1% in 2021. The increase is in addition to the approximately $950million remaining under the previously authorized program. The tables below provide reconciliations of non-GAAP items ($ in millions, except per share data): GAAP net earnings (loss) attributable to Centene, Amortization of acquired intangible assets, Acquisition and divestiture related expenses. These items cannot be reconciled without unreasonable effort. WebBudgeted appropriations included $15,000 for principal,$15,000 for interest, and $4,000 for other items. -- 2022Full Year Diluted EPS of $2.07; Adjusted Diluted EPS of $5.78 --. As of February 7, 2023, there was $700 million available under the senior note debt repurchase program. Centene, like other insurers before it, will be broadening its reach in the Medicare Advantage space in 2022, expanding into 327 new counties and three new (In millions, except shares in thousands and per share data in dollars), LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND STOCKHOLDERS' EQUITY, Preferred stock, $0.001 par value; authorized 10,000 shares; no shares issued or outstanding at December 31, 2022 and December 31, 2021, Common stock, $0.001 par value; authorized 800,000 shares; 607,847 issued and 550,754 outstanding at December 31, 2022, and 602,704 issued and 582,479 outstanding at December 31, 2021, Accumulated other comprehensive earnings (loss), Treasury stock, at cost (57,093 and 20,225 shares, respectively), Total liabilities, redeemable noncontrolling interests and stockholders' equity, Selling, general and administrative expenses, Loss attributable to noncontrolling interests, Net earnings (loss) attributable to Centene Corporation. Adjusted SG&A expense ratio of 8.2% to 8.7%. https://event.webcasts.com/starthere.jsp?ei=1584203&tp_key=4237d69e19, https://investors.centene.com/news-events/events-presentations, Purchase Order Supplemental disclosures of cash flow information: Equity issued in connection with acquisitions. Statement of Operations: Three Months Ended March 31, 2023. Except as may be otherwise required by law, we undertake no obligation to update or revise the forward-looking statements included in this press release, whether as a result of new information, future events, or otherwise, afterthe date hereof. The adjusted SG&A expense ratio was 8.5% for the first quarter of 2023, compared to 7.7% in the first quarter of 2022. The new contract is anticipated to begin January 1, 2023. In addition, the, Preferred stock, $0.001 par value; authorized 10,000 shares; no shares issued or, Common stock, $0.001 par value; authorized 800,000 shares; 614,355 issued and, Net increase (decrease) in cash, cash equivalents, and restricted cash and cash, The following table provides a reconciliation of cash, cash equivalents, and restricted cash and cash equivalents reported within the Consolidated, Purchase Order Increases were also driven by costs associated with Medicare marketing, including annual enrollment, value creation investment spending, and variable compensation. Our local approach allows us to help members access high-quality, culturally sensitive These forward-looking statements reflect our current views with respect to future events and are based on numerous assumptions and assessments made by us in light of our experience and perception of historical trends, current conditions, business strategies, operating environments, future developments, and other factors we believe appropriate. Medicaid and Medicare membership includes 1,323,000 and 1,231,500 Dual Eligible Special Needs Plans (D-SNP)beneficiaries for the periods ending March31, 2023, and March31, 2022, respectively. WebCentene Corporation is followed by the analysts listed below. By continuing to use our site, you agree to our Privacy Policy In particular, these statements include, without limitation, statements about our future operating or financial performance, market opportunity, value creation strategy, competition, expected activities in connection with completed and future acquisitions and dispositions, our investments, and the adequacy of our available cash resources. (1) Membership includes TANF, Medicaid Expansion, CHIP, Foster Care, and Behavioral Health. The Company uses the presented non-GAAP financial measures internally in evaluating the Company's performance and for planning purposes, by allowing management to focus on period-to-period changes in the Company's core business operations, and in determining employee incentive compensation. The Company is unable to provide a reconciliation of its 2022 Adjusted Diluted EPS guidance range to the corresponding GAAP measure without unreasonable effort. Health benefits ratio. Therefore, the Company believes that this information is meaningful in addition to the information contained in the GAAP presentation of financial information. The twelve months ended December 31, 2023 also includes a one-time income tax benefit of $0.12 resulting from the vesting of long-term stock awards distributable to the estate of Mr. Neidorff during Q1 2023. For the full year of 2023, premium and service revenue is coming in stronger than our last midpoint of $132.5 billion driven "This positive momentum positions us well for 2023 and beyond as we maximize the opportunities ahead forour core business.". By their nature, forward-looking statements involve known and unknown risks and uncertainties and are subject to change because they relate to events and depend on circumstances that will occur in the future, including economic, regulatory, competitive and other factors that may cause our or our industry's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Panupong Tejapaibul, chief executive officer and co-founder of Ticketmelon, announced this last month. Terms & Conditions, For the fourth quarter of 2022, total revenues increased 9% to. All forward-looking statements included in this press release are based on information available to us on the date hereof. The three months ended December 31, 2021 include a tax benefit of $0.02 related to the impairment of our equity method investment in RxAdvance. In May, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 7.820% volatility is expected. In February 2023, Centene announced that the Centene Charitable Foundation sponsored National No One Eats Alone Day on February 17. ST. LOUIS, April 25, 2023 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today its financial results for the first quarter ended March 31, 2023. The Company is unable to provide a reconciliation of its 2023 adjusted diluted EPS guidance range to the corresponding GAAP measure without unreasonable effort due to the difficulty of predicting the timing and amounts of various items within a reasonable range. The Company's days in claims payable was 54 days, which is flat as compared to the fourth quarter of 2022, and an increase of one day as compared to the first quarter of 2022. Cash flow used in operations for the fourth quarter of 2022 was, For the full year 2022, total revenues increased 15% to. In April 2023, the Company repurchased an additional 3.0million shares for $200 million. Diluted shares outstanding of 557.5 million to 560.5 million. Net income of $5.0 billion, an increase of 6.5 percent from first-quarter 2022, and adjusted EBITDA 1 of $11.9 billion, down 1.1 percent year over year. For its 2023 fiscal year, the Company's guidance is as follows: In addition, in preparation for the Magellan Specialty divestiture, as well as planning for the future, the Company also announced today that its Board of Directors has authorized a $2.0billion increase to the Company's existing stock repurchase program. In addition, a digital audio playback will be available until 9:00 AM (Eastern Time) on Tuesday, February 14, 2023, by dialing 1-877-344-7529 in the U.S., 1-855-669-9658 in Canada, or +1-412-317-0088 from abroad, and entering access code 9175346. The health of individuals drives our focus on the environment, Additionally, approximately $193 million was recorded as a reduction to premium revenues resulting from development within "Incurred related to: Prior period" due to minimum HBR and other return of premium programs. Transforming the health of the community, one person at a time. (1) A full reconciliation of the adjusted diluted earnings per share (EPS) and adjusted selling, general and administrative (SG&A) expenses is shown in the Non-GAAP Financial Presentation section of this release. Total Broadband: Total broadband net additions of 437,000 was the largest result in more than a decade, reflecting a strong demand for fixed wireless and Fios products. Terms & Conditions, For the first quarter of 2023, premium and service revenues increased 2% to. corporate governance. The income tax effects of adjustments are based on the effective income tax rates applicable to each adjustment. Amazon has decided to shutter its health-focused Halo division, The Verge has learned. GAAP diluted earnings per share attributable to Centene. Total Broadband: Total broadband net additions of 437,000 was the largest result in more than a decade, reflecting a strong demand for fixed wireless and Fios products. Centene believes it has consistently applied its claims reserving methodology. The Company also contracts with other healthcare and commercial organizations to provide a variety of specialty services focused on treating the whole person. It is the premier event technology solutions company for event Oct 06, 2020, 07:00 ET. What Do the Estimates Say? All other investors and interested parties are invited to participate via live webcast on the Company's website at www.centene.com, under the Investors section, or directly via the following link at: https://event.webcasts.com/starthere.jsp?ei=1584203&tp_key=4237d69e19. Centeneoffers affordable and high-quality products to nearly 1 in 15 individuals across the nation, including Medicaid and Medicare members (including Medicare Prescription Drug Plans) as well as individuals and families served by theHealth Insurance Marketplace, the TRICARE program, and individuals in correctional facilities. (3)Adjusted effective tax rate excludes income tax effects of adjustments of approximately $250 million to $260 million. We also delivered strong financial results, exceeding our most recent full year guidance," said Sarah M. London, Chief Executive Officer of Centene. Innovation Service Market 2022 Advance Technology, Latest Trend and Future Expansion by 2030 Published: April 24, 2023 at 9:08 a.m. WebCentenes foundational belief that everyone deserves access to high-quality, affordable healthcare with dignity drives its determination to expand the range of products we offer Centeneoffers affordable and high-quality products to nearly 1 in 15 individuals across the nation, including Medicaid and Medicare members (including Medicare Prescription Drug Plans) as well as individuals and families served by theHealth Insurance Marketplace and the TRICARE program. Centene.com uses cookies. The increases were driven by growth in the Marketplace business, which operates at a higher SG&A ratio. ST. LOUIS, Dec. 16, 2022 /PRNewswire/ -- Centene Corporation (NYSE: CNC) today willhost its investor day to outline its 2023 financial guidance as well as provide updates on its long-term strategic plan, designed to deliver long-termshareholder value. Billund, February 10, 2022: Today, the LEGO Group announced that it will significantly expand and upgrade its global headquarters in Billund, Denmark towards 2025. Terms & Conditions. Total debt was $18.3 billion, which included $359 million of borrowings on our $2.0 billion revolving credit facility at quarter end. The investments include the creation of Kornmarken Campus, which will connect the existing LEGO factory with a new 46,000m2 building. (3) Membership includes Medicare Advantage and Medicare Supplement. Statement of Operations: Three Months Ended March 31, 2023. The presentation of this additional non-GAAP financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP. In summary, the 2023 first quarter results were as follows: Premium and service revenues (in millions), Total cash flow provided by operations (in millions). ST. LOUIS, Oct. 6, 2020 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today it plans to expand its Medicare Advantage offerings for 2021. Costs related to the PBM legal settlement of $2 million. The Company also references a long-term adjusted diluted EPS CAGR target. Centene to grow 26% with 2022 Medicare Advantage expansion Monday, October 4th, 2021 Save Post Listen Text Size Ahead of the 2022 open enrollment period, Centene announced Oct. 4 its plans to expand its Medicare Advantage reach to 327 new counties, marking 26 percent growth. (Operator Instructions) Please note today's event is being recorded. Other adjustments include the following pre-tax items: for the three months ended December 31, 2022: impairments of assets associated with the divestitures of our Centurion and HealthSmart businesses of $293 million; Magellan Rx divestiture gain of $269 million; Health Net Federal Services asset impairment of $233 million; real estate impairments of $61 million; gain on debt extinguishment related to the repurchases of senior notes of $4 million; and costs related to the pharmacy benefits management (PBM) legal settlement of $1 million; for the twelve months ended December 31, 2022: real estate impairments of $1,642 million; PANTHERx divestiture gain of $490 million; impairments of assets associated with the divestitures of our Spanish and Central European, Centurion, and HealthSmart businesses of $458 million; Magellan Rx divestiture gain of $269 million; Health Net Federal Services asset impairment of $233 million; gain on debt extinguishment of $27 million; increase to the previously reported gain on the divestiture of USMM due to the finalization of working capital adjustments of $13 million; and costs related to the PBM legal settlement of $6 million. CENTENE CORPORATION REPORTS FIRST QUARTER 2023 RESULTS. CENTENE CORPORATION REPORTS 2022 RESULTS - Feb 7, 2023 > Press Releases Press Releases CENTENE CORPORATION REPORTS 2022 All forward-looking statements included in this press release are based on information available to us on the date hereof. (3) Membership includes Medicare Advantage and Medicare Supplement. removing social barriers to health, and prioritizing responsible Construction will begin in 2023. and Terms and Conditions. Increases were also driven by costs associated with Medicare marketing, including annual enrollment, and value creation investment spending. The three and twelve months ended December 31, 2022 include tax expense of $107 million related to the Magellan Specialty Health divestiture. Note: Prior period SG&A and adjusted SG&A expense ratios have been restated to conform to current presentation, which excludes depreciation expense. ST. LOUIS, April 25, 2023 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today its financial results for the first quarter ended March31, 2023. For the first quarter 2023, Samsung Biologics recorded a consolidated revenue of KRW 720.9 billion and an operating profit of KRW 191.7 billion. The effective tax rate for the first quarter of 2023 reflects the tax effects of the distribution of long-term stock awards to the estate of the Company's former CEO as well as the Magellan Specialty Health gain. In addition, the three months ended March 31, 2023, includes a one-time income tax benefit $0.13 resulting from the distribution of long-term stock awards to the estate of the Company's former CEO. Centenefocuses on long-term growth and value creation as well as the development of its people, systems, and capabilities so that it can better serve its members, providers, local communities, and government partners. The Company reiterates its 2023 adjusted diluted EPS guidance of $6.25 to $6.40. In addition, the three and twelve months ended December 31, 2022 include tax expense of $3 million and a tax benefit of $15 million, respectively, related to the previously reported impairment of our equity method investment in RxAdvance. Financial and other information about Centene is routinely posted and is accessible on Centene's investor relations website, https://investors.centene.com/. Transforming the health of the community, one person at a time. CENTENE CORPORATION ANNOUNCES 2023 GUIDANCE - Dec 16, 2022 2023 Adjusted Diluted EPS of $6.25 to $6.40 Announces Long-Term Adjusted Diluted (NYSE: CNC) announced today its financial results for the first quarter ended March 31, 2023. During the fourth quarter of 2022, the Company repurchased $58 million of its par value Senior Notes for $53 million through its senior note debt repurchase program and repaid $180 million on its construction loan. Additionally, approximately $198 million was recorded as a reduction to premium revenues resulting from development within "Incurred related to: Prior period" due to minimum HBR and other return of premium programs. CASH, INVESTMENTS AND RESTRICTED DEPOSITS (in millions). Centene uses its investor relations website to publish important information about the Company, including information that may be deemed material to investors. The effective tax rate for 2021 reflects the non-taxable gain related to the acquisition of the remaining 60% interest in Circle Health, the partial non-deductibility of the legal settlement reserve, and the gain on the sale of our majority stake in USMM. Centene price target for 2023 by month Target values for the price of one Centene share for May 2023. The percentage of members in Centene's 4-star or higher plans will drop to 3% from 48% in 2022, Scott Fidel, an analyst at Stephens, estimated in a Friday research note. Fellow managed care insurer Molina Healthcare Inc. also reported its 2022 fourth-quarter earnings this week, notching $8.22 billion in revenue, up from $7.41 billion in the fourth quarter of 2021. Our local approach allows us to help members access high-quality, culturally sensitive During the fourth quarter of 2022, the Company recorded pre-tax impairment charges associated with the divestitures of its Centurion business for. Medicaid and Medicare membership includes 1,291,300 and 1,178,000 dual-eligible beneficiaries for the periods ending December31, 2022, and December31, 2021, respectively. The Company is providing certain non-GAAP financial measures in this report as the Company believes that these figures are helpful in allowing investors to more accurately assess the ongoing nature of the Company's operations and measure the Company's performance more consistently across periods. You should not place undue reliance on any forward-looking statements, as actual results may differ materially from projections, estimates, or other forward-looking statements due to a variety of important factors, variables and events including, but not limited to: our ability to accurately predict and effectively manage health benefits and other operating expenses and reserves, including fluctuations in medical utilization rates due to the ongoing impact of COVID-19; our ability to maintain or achieve improvement in the Centers for Medicare and Medicaid Services (CMS) Star ratings and maintain or achieve improvement in other quality scores in each case that can impact revenue and future growth; the risk that the election of new directors, changes in senior management, and any inability to retain key personnel may create uncertainty or negatively impact our ability to execute quickly and effectively; uncertainty as to the expected financial performance of the combined company following the recent completion of the acquisition of Magellan Health, Inc. (the Magellan Acquisition); the possibility that the expected synergies and value creation from the Magellan Acquisition or the acquisition of WellCare Health Plans, Inc. (the WellCare Acquisition) (or other acquired businesses) will not be realized, or will not be realized within the respective expected time periods; disruption from the integration of the Magellan Acquisition or from the integration of the WellCare Acquisition; unexpected costs, or similar risks, from other acquisitions or dispositions we may announce or complete from time to time, including potential adverse reactions or changes to business relationships with customers, employees, suppliers or regulators, making it more difficult to maintain business and operational relationships; the risk that the closing conditions, including applicable regulatory approvals, for the pending disposition of Magellan Specialty Health may be delayed or not obtained; impairments to real estate, investments, goodwill and intangible assets; a downgrade of the credit rating of our indebtedness; competition; membership and revenue declines or unexpected trends; changes in healthcare practices, new technologies, and advances in medicine; increased healthcare costs; changes in economic, political or market conditions; changes in federal or state laws or regulations, including changes with respect to income tax reform or government healthcare programs as well as changes with respect to the Patient Protection and Affordable Care Act and the Health Care and Education Affordability Reconciliation Act (collectively referred to as the ACA) and any regulations enacted thereunder that may result from changing political conditions, the current administration or judicial actions; rate cuts or other payment reductions or delays by governmental payors and other risks and uncertainties affecting our government businesses; our ability to adequately price products; tax matters; disasters or major epidemics; changes in expected contract start dates; provider, state, federal, foreign and other contract changes and timing of regulatory approval of contracts; the expiration, suspension, or termination of our contracts with federal or state governments (including, but not limited to, Medicaid, Medicare, TRICARE or other customers); the difficulty of predicting the timing or outcome of legal or regulatory proceedings or matters, including, but not limited to, our ability to resolve claims and/or allegations made by states with regard to past practices, including at Envolve Pharmacy Solutions, Inc. (Envolve), as our pharmacy benefits manager (PBM) subsidiary, within the reserve estimate we previously recorded and on other acceptable terms, or at all, or whether additional claims, reviews or investigations relating to our PBM business will be brought by states, the federal government or shareholder litigants, or government investigations; the timing and extent of benefits from our value creation strategy, including the possibility that the benefits received may be lower than expected, may not occur, or will not be realized within the expected time periods; challenges to our contract awards; cyber-attacks or other privacy or data security incidents; the exertion of management's time and our resources, and other expenses incurred and business changes required in connection with complying with the undertakings in connection with any regulatory, governmental or third party consents or approvals for acquisitions or dispositions; any changes in expected closing dates, estimated purchase price and accretion for acquisitions or dispositions; restrictions and limitations in connection with our indebtedness; the availability of debt and equity financing on terms that are favorable to us; inflation; foreign currency fluctuations; and risks and uncertainties discussed in the reports that Centene has filed with the Securities and Exchange Commission.
Ernest Watson Night Life At The Studio, Moshulu Dress Code, When Will Delicate Arch Collapse, Articles C